Table 2.

Multivariable logistic regression analyzing utilization of immunotherapy among patients with metastatic pancreatic ductal adenocarcinoma (National Cancer Database, 2004–2016)

	OR	95% CI	p
Age	0.99	0.98–1.00	0.046
Female vs. male	1.01	0.82–1.25	0.929
White vs. other race	1.30	0.99–1.71	0.055
Private insurance vs. other	1.23	0.96–1.56	0.100
Top 2 income quartiles vs. bottom	0.86	0.66–1.12	0.277
Top 2 education quartiles vs. bottom	1.34	1.03–1.74	0.031
Academic facility vs. other	1.95	1.58–2.41	<0.001
Charlson–Deyo score ≥1 vs. 0	0.77	0.60–0.99	0.040

Bold values indicate statistical significance.

95% CI, 95% confidence intervals; OR, odds ratio.